Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis

Sponsor
Geisinger Clinic
Study ID
NCT07784712
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 105 Years
Healthy Volunteers
Not accepted

Study Details

People eligible for this study have had the suggestion from their doctor to receive a cardiac pacemaker or defibrillator to treat a cardiac condition as part of their routine care. We are doing this study to understand if obtaining a tissue sample from their body during a device implant may assist in the early diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CM).

Key Dates

First listed
Aug 25, 2026
Start date
Oct 31, 2026
Status verified
Aug 2026
Primary completion
Apr 30, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
70 participants (estimated)

Primary Outcome Measure

Cardiac biopsy results [ Time Frame: From enrollment to the end of treatment at 15-21 months. ]

Central Contacts

Find similar trials

Nationwide
Heart failure trialsCardiology trialsHeart disease trials

Related Studies